A 26-year-old male with ulcerative pancolitis diagnosed 11 years before, with episodes of severe colitis and steroid-dependent disease, was initially managed with azathioprine and infliximab, latter switched to adalimumab due to an infusion reaction. For the past 7 years he had been under adalimumab 40mg every 2 weeks and messalazine 1,5g/day, with complete remission.